Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors
Crossref DOI link: https://doi.org/10.1007/s12325-020-01221-4
Published Online: 2020-01-18
Published Print: 2020-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nadler, Eric
Pavilack, Melissa
Espirito, Janet L.
Clark, Jamyia
Fernandes, Ancilla
Funding for this research was provided by:
AstraZeneca
Text and Data Mining valid from 2020-01-18
Version of Record valid from 2020-01-18
Article History
Received: 18 November 2019
First Online: 18 January 2020